Analyst Research: Orexigen Therapeutics Inc (OREX.OQ)
OREX.OQ on NASDAQ Stock Exchange Global Select Market
7.55USD
3:32pm EDT
7.55USD
3:32pm EDT
Price Change (% chg)
$0.01 (+0.20%)
$0.01 (+0.20%)
Prev Close
$7.54
$7.54
Open
$7.51
$7.51
Day's High
$7.66
$7.66
Day's Low
$7.46
$7.46
Volume
160,108
160,108
Avg. Vol
337,439
337,439
52-wk High
$7.84
$7.84
52-wk Low
$3.77
$3.77
| Name | Age | Since | Current Position |
|---|---|---|---|
Eckard Weber |
2009 | Independent Chairman of the Board | |
Michael Narachi |
53 | 2009 | President, Chief Executive Officer, Director |
Joseph Hagan |
43 | 2011 | Acting Chief Financial Officer, Treasurer, Chief Business Officer |
Heather Turner |
39 | 2010 | Senior Vice President, General Counsel, Secretary |
Preston Klassen |
43 | 2009 | Head of Global Contrave Program, Senior Vice President - Product Development |

